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Abstract
Background: There is pressing need to diagnose lung cancer earlier in the United Kingdom (UK) and it is likely
that research using computerised general practice records will help this process. Linkage of these records to area-
level geo-demographic classifications may also facilitate case ascertainment for public health programmes,
however, there have as yet been no extensive studies of data validity for such purposes.
Methods: To first address the need for validation, we assessed the completeness and representativeness of lung
cancer data from The Health Improvement Network (THIN) national primary care database by comparing incidence
and survival between 2000 and 2009 with the UK National Cancer Registry and the National Lung Cancer Audit
Database. Secondly, we explored the potential of a geo-demographic social marketing tool to facilitate disease
ascertainment by using Experian’s Mosaic Public Sector ™ classification, to identify detailed profiles of the sectors
of society where lung cancer incidence was highest.
Results: Overall incidence of lung cancer (41.4/100, 000 person-years, 95% confidence interval 40.6-42.1) and
median survival (232 days) were similar to other national data; The incidence rate in THIN from 2003-2006 was
found to be just over 93% of the national cancer registry rate. Incidence increased considerably with area-level
deprivation measured by the Townsend Index and was highest in the North-West of England (65.1/100, 000
person-years). Wider variations in incidence were however identified using Mosaic classifications with the highest
incidence in Mosaic Public Sector ™types ‘Cared-for pensioners, ‘‘ Old people in flats’ and ‘Dignified dependency’
(191.7, 174.2 and 117.1 per 100, 000 person-years respectively).
Conclusions: Routine electronic data in THIN are a valid source of lung cancer information. Mosaic ™ identified
greater incidence differentials than standard area-level measures and as such could be used as a tool for public
health programmes to ascertain future cases more effectively.
Background
More than two-thirds of people with lung cancer in the
United Kingdom (UK) have advanced disease at the time
of diagnosis when curative treatment can no longer be
offered [1,2]. There exists socioeconomic variations in
the incidence of lung cancer [3,4] and evidence from stu-
dies of other cancer screening services and treatments
show unequal participation among different population
sub-groups in screening services [5] as well as inequity in
cancer treatment [6]. To increase earlier ascertainment of
lung cancer and reduce lung cancer-related health
inequalities, there is a public health need to enhance lung
cancer awareness especially in sectors of society where
lung cancer incidence is typically high, with a view to
shorten the interval between symptoms and presentation
to primary care. Computerised general practice records
present a potentially useful source of data to understand
the current pathway of lung cancer diagnosis in general
practice as well as identify the societal distribution of
lung cancer but their validity has yet to be established [7].
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puterised longitudinal database of UK general practice
records. It has been demonstrated to have high quality
data [8] with a high degree of completeness and accu-
racy for records of cancer incidence [9] as well as other
diagnoses [10-12]. THIN has not been fully exploited
for lung cancer studies and its usefulness for lung can-
cer research will depend on its level of ascertainment
and representativeness of lung cancer in the UK.
In addition to routine health information, patients’
records in THIN have area-level information such as Stra-
tegic Health Authority (SHA) regions and the Townsend
Index of multiple deprivation, which have been linked to
patients’ home postcodes. More recently, patients’ records
have also been linked to the Mosaic Public Sector ™
variable which is a consumer classification system origin-
ally designed by Experian to profile customers for the
purpose of market research [13]. Compared with the well-
known and commonly used Townsend Index [14] which
measures the area-based level of material deprivation
using four indicators: unemployment, car ownership,
house ownership and overcrowding, Mosaic Public Sector
™ classifications take account of more granular character-
istics of the population living at different UK postcodes
and therefore allows a clearer identification of the charac-
teristics and differing needs of people [15]. To date,
Mosaic classification has been used to a limited extent for
the targeting of population public health services to those
most in need [16] and studies have usefully applied it to
demonstrate social disparities in health-related behaviours
such as heavy episodic drinking [17] and smoking preva-
lence [18].
The aims of this study were firstly, to assess the comple-
teness and representativeness of overall and area-level
lung cancer data in THIN and secondly, using Experian’s
Mosaic Public Sector ™ classification, identify the particu-
lar sectors of UK society where lung cancer incidence was
highest. This could enable focused and targeted public
health efforts to improve lung cancer awareness and care.
Methods
The Health Improvement Network database is a compu-
terised longitudinal database of general practice records
that are collected regularly from each practice’s clinical
system without intervention to normal practice operation
[19]. At the time of this study, THIN had data from 446
UK general practices with a total of 8.2 million people of
which more than 3.2 million were actively registered and
could be prospectively followed [19].
We identified all patients with a first recorded diagnosis
of lung cancer from the 1st of January 2000 to the 28th of
July 2009, which was the last date of data collection (Read
codes for lung cancer diagnosis available on request) and
then excluded all patients with codes for mesothelioma.
Analysis was done using incident cases of lung cancer in
order to obtain a measure of true survival of lung cancer
patients and therefore avoid any survival bias that may
arise with prevalent cases. To ensure that we had only
incident cases, we included only patients who had been
registered in the practice for at least 1 year prior to their
first diagnosis of lung cancer. The denominator for inci-
dence analyses included all patients in THIN general prac-
tices who had contributed data after the 1st of January
2000 and who had at least one year of data in the dataset.
Incidence rates with 95% confidence intervals (CI) were
calculated as the total number of new lung cancer cases
per 100, 000 person-years at risk. To assess the complete-
ness of lung cancer ascertainment in THIN general prac-
tices and whether this varied by different UK SHA
regions, we calculated the THIN lung cancer incidence
rates from 2006-2008 (period when lung cancer recording
in our database was deemed most reliable) for each SHA
and compared these with the 2003-2007 lung cancer rates
recorded by the National Cancer Registry [20].
Overall incidence rates in the population were calculated
for the study period (2000- 2009) and the results were
stratified by calendar years (3-year periods), age (10-year
age bands up to ≥ 90 years), sex, socioeconomic status and
SHA region. Our measure of socioeconomic status was
the Townsend Index of multiple deprivation in quintiles
for each output area (approximately 150 households)
using the 2001 census data [19]. We also calculated lung
cancer incidence rates by Mosaic Public Sector ™ groups
and types. Mosaic Public Sector ™ classification refines
areas at a higher level than available deprivation markers
by using data from 400 variables to classify all unique
postcodes (approximately 15 to 20 households [21]) within
the UK into 61 types, each type being a member of one of
11 groups (Additional file 1 Table S1). Classification is
based on typical neighbourhood demographics, behaviour,
consumer values, consumption patterns, lifestyle, educa-
tion and social and health-related attitudes [22]. Because
a g ea n ds e xa r eu s e di np a r tt od e r i v et h eM o s a i cP u b l i c
Sector ™ classification, we did not adjust our Mosaic
models for these covariates. Incidence rate ratios (IRR)
between different population strata were obtained using
multivariate Cox proportional hazards regression. We
further analysed the incidence rate ratios using separate
random effects Poisson regression models to adjust for
any effects due to the variable reporting in general prac-
tices [23].
Lung cancer survival rates were calculated from the per-
iod of first recorded lung cancer diagnosis to death or the
date of last data collection from the general practice. To
further validate the lung cancer data in THIN, survival
rates of lung cancer in THIN were compared with rates in
the National Lung Cancer Audit database (LUCADA) [1],
which is a good source of highly representative information
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trusts throughout England, Wales and Scotland. Cox pro-
portional hazards models were used to model survival data
with age, sex and socioeconomic status to determine the
relationship between these factors and lung cancer survival.
The Cox proportional hazards assumption was assessed for
each of the models by plotting the log minus log transfor-
mation of the Kaplan-Meier estimator of the survival func-
tion against time.
All analyses were done using STATA release SE11
[24] and the study protocol was reviewed and approved
in 2009 by the Cegedim Strategic Data Medical Research
Scientific Review Committee.
Results
We identified a total of 12, 135 incident cases of lung can-
cer recorded in THIN between the 1st of January 2000
and the 28th of July 2009. There were 7, 184 males and 4,
951 females comprising 59.2% and 40.8% of all lung cancer
cases respectively. The median age at lung cancer diagno-
sis was 72.6 years (Inter-quartile range [IQR]: 64.5-79.0).
The median age at lung cancer death was 73.8 years (IQR:
65.7-80.0).
Lung cancer incidence
The overall incidence of lung cancer in THIN for the
whole study period from 2000 to 2009 was 41.4 per 100,
000 person-years (95% CI 40.6-42.1) (Table 1). There was
an increase in the overall incidence of lung cancer by
approximately 4% for every 3-year period (IRR 1.04, 95%
CI 1.04-1.05) (Figure 1). The incidence rate in the 3-year
period 2000-2002 was 33.1 per 100, 000 person years (95%
CI 31.9-34.3). The incidence rate in 2003-2005 was 42.8
per 100, 000 person years (95% CI 41.5-44.2), incidence in
2006-2008 was 46.8 per 100, 000 person years (95% CI
45.4-48.2) and the incidence rate in 2009 was 45.1 per
100, 000 person years (95% CI 42.0-48.4).
Table 1 shows the variation in lung cancer incidence by
sex and age. Incidence rates were 50% higher in males
(49.4 per 100, 000 person-years, 95% CI 48.2-50.5)
compared with females (33.5 per 100, 000 person-years,
95% CI 32.6-34.4) and increased with age, reaching a peak
in the 80-90 year age-group in males and in the 70-80 year
age-group in females.
Table 2 shows that the overall lung cancer incidence
rate in THIN for all the SHAs between 2006-2008 was
46.8 per 100, 000 person-years accounting for 93.2% of the
national cancer registry incidence rate of 50.2 per 100, 000
person-years. The highest rates of lung cancer in THIN
were in the North-West of England followed by Scotland
and the North-East of England and this pattern was simi-
lar over the entire study period from 2000-2009 (data for
entire study period not shown). The lowest incidence rates
were in London and the South-East coast. Comparing
lung cancer incidence rates in THIN in the SHA regions
over the 3 year period from 2006-2008 (when lung cancer
incidence in THIN had increased from the initial stages of
the study and reached a plateau) with national cancer reg-
istry rates, the rates in THIN and registry were compar-
able in 9 of the 13 SHAs. THIN incidence rates were
higher than registry rates in the South-West of England
but the rates were lower than registry rates in London,
Northern Ireland and the West Midlands.
We found a strong relationship between socioeconomic
deprivation and lung cancer incidence (Table 3). Using the
Townsend Index as a measure of area level deprivation,
the highest lung cancer incidence rate of 61.5 per 100, 000
person-years (95% CI 59.1-64.1) in the most deprived
Townsend quintile was over twice the incidence rate of
28.7 per 100, 000 person-years (95% CI 27.5-30.0) in the
least deprived quintile. After adjusting for the effects of
age, sex and general practice (Table 3 & Figure 2), there
was an 11% increase in lung cancer incidence for every
category increase in Townsend quintile (IRR 1.11, 95% CI
1.10-1.12) and the rate of lung cancer among people in the
most deprived Townsend quintile was 2.2 times higher
than the rate in the least deprived quintile (IRR 2.2, 95%
CI 2.0-2.3).
Compared with Townsend Index quintiles, there
were wider variations in the incidence of lung cancer
Table 1 Overall incidence rates of lung cancer by age group and sex (2000-2009)
Age group
(years)
Lung cancer events 100, 000
Person-yrs at risk
Rate/100, 000 person-years (95% CI)
Male Female Male Female All Male Female
0-40 30 29 75.6 72.4 0.4 (0.3-0.5) 0.4 (0.3-0.6) 0.4 (0.3-0.6)
40-50 168 147 22.1 21.3 7.3 (6.5-8.1) 7.6 (6.5-8.8) 6.9 (5.9-8.1)
50-60 793 574 19.3 18.9 35.7 (33.9-37.7) 41.0 (38.3-44.0) 30.3 (28.0-33.0)
60-70 1951 1285 14.5 14.9 110.0 (110-110) 134.4 (130-140) 86.3 (81.7-91.1)
70-80 2737 1781 9.6 11.7 212.0 (210-220) 286.2 (280-300) 151.6 (140-160)
80-90 1365 1029 3.9 7.0 219.4 (210-230) 348.1 (330-370) 147.2 (140-160)
> 90 139 105 0.5 1.5 120.2 (110-140) 283.7 (240-340) 68.2 (56.3-82.5)
All ages 7184 4951 145.5 147.8 41.4 (40.6-42.1) 49.4 (48.2-50.5) 33.5 (32.6-34.4)
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Page 3 of 9across Mosaic Public Sector ™ groups (Table 3 & Fig-
u r e2 ) .T h eh i g h e s tl u n gc a n c e ri n c i d e n c er a t eo f1 2 9 . 3
per 100, 000 person-years (95% CI 121.0-138.2) was
found in Mosaic Public Sector ™ group I (Twilight
subsistence). Mosaic Public Sector ™ groups F, G and
J also had high rates of lung cancer incidence. After
adjusting for the effects of general practice, the lung
cancer incidence rate in Mosaic group I where inci-
dence was highest, was 6.6 times higher when com-
pared with the rate in Mosaic group B where the
incidence of lung cancer was lowest (IRR 6.65, 95% CI
6.0-7.4)
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Figure 1 Trend in incidence of lung cancer, 2000-2009. Bars represent 95% confidence intervals.
Table 2 Distribution of THIN lung cancer cases by UK Strategic Health Authority region
Strategic
health
authority
(SHA)
Number of new
cases of lung
cancer in THIN
2006-2008
100, 000
person
years at
risk
THIN 2006-2008 lung
cancer incidence rates/
100, 000 person years
(95% CI)
UK national cancer registry age-
standardised incidence rates of lung
cancer (2003-2007)/100, 000 person yrs
[35]
Crude lung cancer
incidence rate ratio (THIN
compared to Registry
rates)
East
Midlands
172 4.1 41.7 (35.9-48.4) 47.1 (46.3-47.9) 0.89
East of
England
331 7.6 43.5 (39.1-48.5) 40.6 (39.9-41.2) 1.07
London* 358 9.9 36.1 (32.5-40.0) 48.7 (48.0-49.4) 0.74
North East 211 3.3 63.6 (55.5-72.7) 68.2 (66.9-69.5) 0.93
North West 605 9.3 65.1 (60.1-70.5) 59.3 (58.6-60.1) 1.10
Northern
Ireland*
146 3.8 38.8 (33.0-45.6) 49.2 (47.8-50.6) 0.79
Scotland 479 7.4 64.9 (59.4-71.0) 69.2 (68.3-70.1) 0.94
South
Central
459 11.3 40.5 (36.9-44.4) 39.4 (38.6-40.2) 1.03
South East
Coast
337 9.3 36.1 (32.5-40.2) 39.7 (39.0-40.5) 0.91
South
West**
476 10.2 46.5 (42.5-50.8) 38.9 (38.3-39.6) 1.20
Wales 319 6.1 52.6 (47.2-58.7) 52.8 (51.8-53.9) 1.00
West
Midlands*
372 9.3 39.8 (36.0-44.1) 46.5 (45.8-47.2) 0.86
Yorkshire &
Humber
233 4.4 52.6 (46.2-59.8) 56.9 (56.0-57.7) 0.92
Overall 4498 96.2 46.8 (45.4-48.2) 50.2 (49.9-50.5) 0.93
* SHAs with lower incidence of lung cancer recorded in THIN compared to national cancer registry
** SHAs with higher incidence of lung cancer recorded in THIN compared to national cancer registry
(There is an overlap of the 95% confidence intervals in the incidence rates in the other 9 SHAs)
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Page 4 of 9Table 3 Overall incidence of lung cancer by Townsend Index quintiles and Mosaic Public Sector™ groups
Lung ca events Person-yrs at risk Rate per 100, 000 p/y (95% CI) Incidence rate ratios (95% CI) §
Townsend index of deprivation
1 (least deprived) 2069 72.0 28.7 (27.5- 30.0) 1.00
2 2243 61.4 36.5 (35.1- 38.1) 1.20(1.12-1.27)
3 2439 58.1 42.0 (40.4- 43.7) 1.49(1.41-1.59)
4 2653 51.4 51.7 (49.8- 53.7) 1.86(1.75-1.98)
5 (most deprived) 2245 36.4 61.5 (59.1- 64.1) 2.16 (2.02-2.31)
Missing 484 14.0 34.5 (31.5- 37.7) 1.29(1.14-1.46)
Mosaic Public Sector ™ group
A (Symbols of success) 690 27.9 24.7 (23.0- 26.6) 1.38(1.24-1.54)
B (Happy families) 613 34.9 17.6 (16.2- 19.0) 1.00
C (Suburban comfort) 1700 46.7 36.4 (34.7- 38.1) 2.02(1.84-2.21)
D (Ties of community) 1608 40.0 40.2 (38.2- 42.2) 2.27(2.07-2.50)
E (Urban intelligence) 233 11.4 20.5 (18.0- 23.3) 1.28(1.10-1.49)
F (Welfare borderline) 566 9.0 62.6 (57.6- 68.0) 3.65(3.26-4.09)
G (Municipal dependency) 1008 15.4 65.5 (61.6- 70.0) 3.67(3.32-4.06)
H (Blue collar enterprise) 1791 33.4 53.7 (51.2- 56.2) 2.99(2.73-3.28)
I (Twilight subsistence) 866 6.7 129.3 (121.0- 138.2) 7.29(6.58-8.09)
J (Grey perspectives) 1239 20.4 60.7 (57.4- 64.2) 3.44(3.13-3.79)
K (Rural isolation) 425 14.1 30.0 (27.3- 33.0) 1.69(1.49-1.91)
99 (Missing) 1394 33.3 41.9 (39.8- 44.2) 2.55(2.32-2.80)
§ Townsend Index incidence rate ratios adjusted for age, sex and general practice
Mosaic Public Sector group incidence rate ratios adjusted for general practice
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Figure 2 Lung cancer incidence rate ratios by Mosaic Public Sector ™ groups and by Townsend quintiles (adjusted for age and sex).
Reference groups (Mosaic group B; Townsend quintile 1).
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Page 5 of 9Analyses of the 61 Mosaic Public Sector ™ types (Figure
3) showed the highest lung cancer incidence rate of 191.7
per 100, 000 person-years (95% CI 173.8-211.5) in Mosaic
Public Sector ™ type I50 (Cared for pensioners). The next
highest incidence rate of 174.2 per 100, 000 person-years
(95% CI 151.1-200.7) was found in Mosaic Public Sector
™ type I48 (Old people in flats). Lung cancer incidence
was lowest for people in Mosaic Public Sector ™ type B10
(Upscale new owners) with a rate of 6.2 per 100, 000 per-
son-years (95% CI 4.4-8.7). The incidence rate of lung can-
cer in Mosaic type I50 was 31.2 times higher (IRR 31.2,
95% CI 21.9-44.5) when compared to the rate in Mosaic
type B10. Table 4 summarizes the typical characteristics of
the Mosaic Public Sector ™ groups and types where lung
cancer incidences were highest in the UK.
Lung cancer survival
Among the 12, 135 lung cancer cases studied, 8, 885
(73.2%) died during the study period. Six months after
diagnosis, 57% of the cases were still alive; one year after,
37% of the cases were alive and five years after, only 11%
of the cases were alive. The median survival of the cases
was 232 days (IQR: 76-630 days). This was only slightly
better than survival in LUCADA where the median survi-
val was 203 days with a one year survival of 32%.
Male lung cancer patients died earlier than female
patients with a median survival for males of 221 days
(IQR: 72-580 days) compared with 251 days (IQR: 83-709
days) for females. The percentages of males alive at 6
months, 1 year and 5 years after diagnosis were 55%, 36%
and 10% respectively. Survival for females on the other
hand at 6 months, 1 year and 5 years were 59%, 40% and
12% respectively. Survival for patients in THIN was bet-
ter than survival in the cancer registry [25], where the
one year lung cancer survival was 27% for men and 30%
for women. After adjusting for the effect of age at diagno-
sis, male lung cancer patients in THIN had 11% worse
survival than female lung cancer patients (Hazards ratio
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Mosaic type
Figure 3 Lung cancer incidence by Mosaic Public Sector ™ type.
Table 4 Mosaic groups and types with the highest incidence of lung cancer
Mosaic groups Characteristics
I Twilight subsistence Older people living in social housing with high care needs
G Municipal dependency Low income families living in estate based social housing
F Welfare borderline People living in social housing with uncertain unemployment in deprived areas
Mosaic types Characteristics
I50 Cared-for pensioners Older people receiving care in homes or sheltered accommodation
I48 Old people in flats Older people living in small council and housing association flats
F39 Dignified dependency Low income couples and pensioners living in crowded apartments in high density social housing
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Page 6 of 9for death - 1.11, 95% CI 1.06 to 1.16). Table 5 shows that
lung cancer survival worsened with increasing age at
diagnosis. Using the Townsend index deprivation quintile
as a measure of socioeconomic status, survival did not
differ across socioeconomic groups.
Discussion
The overall incidence rate of lung cancer recorded in
THIN general practices was 41.4 per 100, 000 person-
years between 2000 and 2009, however incidence from
2000-2002 was lower than in the latter periods of the
study. This supports findings from a previous study which
showed that the observed recording rates of pancreatic,
colorectal and lung cancers in THIN prior to 2004 were
lower than expected based on the national cancer registry
data but increased to approximately 80% of registry rates
after 2004 [9]. It has been suggested that a large increase
in the recruitment of general practices to THIN in 2003
associated with receipt of training in data entry, experience
in using the Vision software, and the institution of cancer
quality improvement measures by the national Health Ser-
vice in 2003 may have all contributed to the increase in
recording of these cancers [9]. The introduction of the
Quality and Outcomes Framework (QOF) [26] in 2004
which encourages general practitioners to record all new
cases of cancer may also partly explain the increase in can-
cer recording in THIN. After comparing the lung cancer
incidence rate in THIN with incidence rate recorded by
the national cancer registry [20], our study confirms that
THIN captures a significantly higher proportion of lung
cancer incidence in more recent years.
Lung cancer Incidence
There are two reliable national lung cancer databases in
the UK against which THIN data can be compared to
assess its completeness and representativeness. These are
the National Lung Cancer Audit database (LUCADA) [1]
which has been shown to be highly representative of peo-
ple with lung cancer in England [27]; and the national
cancer registry data reported by the Office of National
Statistics (ONS) [28] which is a good source of informa-
tion on lung cancer incidence. Data reported by the ONS
are systematically collected from all regional cancer regis-
tries in England, Wales, Scotland and Northern Ireland.
Reassuringly, the sex distribution of lung cancer cases
in THIN, the median age at diagnosis and at death, and
the increasing incidence with greater socioeconomic
deprivation were all comparable to findings from
LUCADA [27]. Comparison of the lung cancer incidence
rate in THIN with the incidence rate reported by the
national cancer registry [20], showed the incidence rate
in THIN to be over 93% of the cancer registry incidence
rate. Geographical variations in lung cancer incidence in
THIN were also mostly similar to registry data. The high-
est incidence rates were in the North-West of England,
North-East of England and Scotland while the South East
Coast and London had the lowest incidence. Cancer reg-
i s t r yd a t ah o w e v e r ,s h o w si n c i d e n c ei nL o n d o nt ob e
exceptionally high compared to other SHA regions in
southern England. This is in contrast to THIN where the
lowest incidence of lung cancer was in London, which
may be due to THIN’s over recruitment of practices cov-
ering slightly more affluent areas [29,30]. The population
of THIN also has an over-representation of practices
from the South-East of England where incidence rates
are among the lowest so it is therefore unsurprising that
the crude overall lung cancer incidence in THIN is mar-
ginally lower than the incidence rates based on registry
data. The difference between THIN and registry inci-
dence rates may also be partly attributed to the fact that
Table 5 Survival of lung cancer patients by age at diagnosis and Townsend quintiles
Median survival in days (IQR) 6 months survival 1-year survival 5-year survival Unadjusted hazards ratio 95% CI p-value
Age at diagnosis (years)
< 40 457 (248- .) 85% 52% 31% 1.00 - -
40-50 341 (148-1150) 70% 48% 17% 1.35 0.92-1.97 0.126
50-60 287 (116-830) 65% 42% 15% 1.54 1.08-2.20 0.018
60-70 274 (85-736) 61% 42% 13% 1.68 1.18-2.40 0.004
70-80 218 (72-604) 55% 36% 9% 1.94 1.36-2.77 < 0.001
80-90 164 (54-443) 47% 29% 6% 2.41 1.69-3.45 < 0.001
> 90 147 (46-403) 40% 26% - 2.72 1.85-4.01 < 0.001
Townsend score (quintiles)
1 223 (78-593) 56% 37% 9.7% 1.00 - -
2 232 (79-640) 57% 36% 10% 0.98 0.91-1.05 0.53
3 224 (67-587) 56% 36% 9.9% 1.03 0.96-1.10 0.46
4 242 (76-666) 58% 39% 12% 0.94 0.88-1.01 0.10
5 221 (72-608) 55% 37% 10% 1.01 0.94-1.09 0.82
missing 296 (116-1032) 64% 44% 18% 0.78 0.68-0.88 < 0.001
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Page 7 of 9about 6.8% of cases included in the UK cancer registries
are from death certificates only [31].
Societal distribution of lung cancer
The association we found between lung cancer incidence
and greater socioeconomic deprivation was independent
of age, sex and general practice and is consistent with find-
ings from other studies [3,4]. Variations in lung cancer
incidence were however, more marked in the Mosaic
groups and types than in Townsend deprivation quintiles.
Mosaic Public Sector ™ segmentation classifies UK house-
holds and postcodes into several lifestyle groups and types
based on finer characteristics which enabled us to identify
much higher incidence rates of lung cancer in specific sec-
tors of society. Mosaic Public Sector ™ types I50 (Cared
for pensioners), I48 (Old people in flats) and F39 (Digni-
fied dependency) had the highest lung cancer incidence
rates and this was unsurprising considering the fact that
t h e s eM o s a i cP u b l i cS e c t o r™ types are characterised
mostly by older people who have poor levels of education,
are mostly reliant on state benefits and live relatively less
healthy lifestyles including above average smoking rates.
Mosaic classification is done at the household as well
as the postcode level and although about half (54%) of
the data used for Mosaic profiling are sourced from the
2001 census, the other 46% are derived from sources
such as the Experian Lifestyle Survey, consumer credit
databases, the electoral roll, shareholder registers, Land
registry data, Council Tax information, the Hospital Epi-
sode Statistics, the British Crime Survey, Expenditure
and Food Survey and other sources [13]. Mosaic profil-
ing is therefore based on an exchange of information
which enhances a deeper understanding of the charac-
t e r i s t i c so fp e o p l ei nt h ev a r i o u sg r o u p sa n dt y p e s[ 1 5 ]
unlike the Townsend Index which uses a less complex
classification of postcodes based on measures of socioe-
conomic deprivation from census data [14]. To accu-
rately target public health resources and develop
tailored public health campaigns and interventions, the
differing needs of deprived populations have to be iden-
tified and understood and in this regard, Mosaic classifi-
cation is particularly valuable.
Lung cancer survival
Median survival for people with lung cancer in THIN
was only slightly better than survival in LUCADA [27].
The survival estimates in THIN and LUCADA were
marginally higher when compared with survival in the
cancer registry [25] and most likely reflect the different
methods of case ascertainment [32]; in particular, the
registry ascertains cases with a diagnosis of lung cancer
only on a death certificate whilst these cases, having no
supporting clinical data prior to death, may not have
been recorded in THIN nor LUCADA.
Socioeconomic deprivation did not affect survival of
people with lung cancer in THIN and this is consistent
with the findings from LUCADA [27]. This lack of asso-
ciation may reflect the dismal prognosis of lung cancer
in general and the lack of effective treatments for most
people with lung cancer.
A major strength of this study is that Experian’s
Mosaic Public Sector ™ classification tool provides a
finer and more detailed classification of the UK popula-
tion than any other socio-demographic classification
m a r k e r ss u c ha sT o w n s e n dd eprivation index [14] and
therefore allows programs and interventions to be tai-
lored to the specific needs of the population.
Potential limitations of using routine general practice
data for research is that detailed diagnostic criteria for
medical conditions may vary between practices and
between doctors in the same practice [33] and analyses
using these data assume the best diagnostic formulation
without taking account variations in the perception of
morbidity. The diagnosis of lung cancer is however
made following investigations carried out by chest physi-
cians in secondary care [34]. It is therefore unlikely that
differences in GPs diagnostic criteria or perception of
the disease would have had a large impact on the
records of lung cancer in this analysis.
Conclusion
Our analyses have shown that general practice data from
THIN are representative of lung cancer in the UK and
capture the vast majority of cases from cancer registries.
UK general practice data are thus a potentially valuable
tool for lung cancer research as they are the only source of
detailed prospectively collected health information avail-
able at a population level both before and after lung cancer
diagnosis. Linkage of patients’ records to Experian’s
Mosaic Public Sector ™ classification has also provided us
with a more refined knowledge of the sectors of society
where lung cancer incidence is highest in the UK. As such,
Mosaic could be used outside general practice as an
important tool to reduce lung cancer-related health
inequalities by enabling tailored public health campaigns
and interventions to be more precisely and thus effectively
targeted geographically to specific lifestyle groups in
society.
Additional material
Additional file 1: Mosaic Public Sector ™™ groups and types.
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